Media coverage about CME Group (NASDAQ:CME) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 45.5381920695216 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

Shares of CME Group (CME) opened at $140.06 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $47.69 billion, a P/E ratio of 29.35, a price-to-earnings-growth ratio of 2.87 and a beta of 0.71.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million during the quarter, compared to analyst estimates of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. CME Group’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.05 EPS. analysts predict that CME Group will post 4.8 earnings per share for the current fiscal year.

A number of research firms have recently weighed in on CME. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Citigroup Inc increased their price objective on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Jefferies Group LLC reissued a “buy” rating and set a $134.00 price objective (up previously from $128.00) on shares of CME Group in a research note on Monday, July 17th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Finally, Barclays PLC began coverage on CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 price objective for the company. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $138.89.

TRADEMARK VIOLATION NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact CME Group (CME) Share Price” was reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at

In other CME Group news, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total transaction of $722,947.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Bryan T. Durkin sold 9,200 shares of the business’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the sale, the president now owns 70,938 shares of the company’s stock, valued at approximately $8,876,471.94. The disclosure for this sale can be found here. Insiders have sold a total of 32,654 shares of company stock valued at $4,221,868 in the last 90 days. 0.57% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.